Transmembrane Domain Targeting Peptide Antagonizing ErbB2/Neu Inhibits Breast Tumor Growth and Metastasis-Reference-Cited by-同舟云学术

Transmembrane Domain Targeting Peptide Antagonizing ErbB2/Neu Inhibits Breast Tumor Growth and Metastasis

Published:2014-09 Issue:6 Volume:8 Page:1714-1721
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Arpel Alexia,Sawma Paul,Spenlé Caroline,Fritz Justine,Meyer Lionel,Garnier Norbert,Velázquez-Quesada Inés,Hussenet Thomas,Aci-Sèche Samia,Baumlin Nadège,Genest Monique,Brasse David,Hubert Pierre,Crémel Gérard,Orend Gertraud,Laquerrière Patrice,Bagnard Dominique

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference25 articles.

1. Architecture and membrane interactions of the EGF receptor;Arkhipov;Cell,2013

2. Treatment of HER2-positive breast cancer: current status and future perspectives;Arteaga;Nat Rev Clin Oncol,2012

3. Molecular modeling of nearly full-length ErbB2 receptor;Bagossi;Biophys. J.,2005

4. Transmembrane peptides as inhibitors of ErbB receptor signaling;Bennasroune;Mol. Biol. Cell,2004

5. Structure elucidation of dimeric transmembrane domains of bitopic proteins;Bocharov;Cell Adhes. Migr.,2010

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydrophobic moment drives penetration of bacterial membranes by transmembrane peptides;Journal of Biological Chemistry;2023-11

2. A combination of a cell penetrating peptide and a protein translation inhibitor kills metastatic breast cancer cells;Cell Death Discovery;2023-08-31

3. The adipose‐derived stem cell peptide ADSCP2 alleviates hypertrophic scar fibrosis via binding with pyruvate carboxylase and remodeling the metabolic landscape;Acta Physiologica;2023-06-27

4. Transmembrane dimers of type 1 receptors sample alternate configurations: MD simulations using coarse grain Martini 3 versus AlphaFold2 Multimer;Structure;2023-06

5. Implication of the Transmembrane Domain in the Interleukin 10 Receptor Platform Oligomerisation;Cells;2023-05-10